Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cue Biopharma Inc (CUE)

52 + Investors. Track Smart Money conviction in CUE. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +4
Streak
1Q ▲
Buyers last Q
49%

Smart Money Signals — CUE

Based on 52 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added CUE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🔻

Below peak — only 68% of 3.0Y high

68% of all-time peak
Only 52 funds hold CUE today versus a peak of 76 funds at 2023 Q2 — just 68% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q
+2 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 49% buying

18 buying19 selling
Last quarter: 19 funds reduced or exited vs 18 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
📈

More new buyers each quarter (+6 vs last Q)

new funds entering per quarter
Funds opening a new CUE position: 8 → 9 → 7 → 13. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

58% of holders stayed for 2+ years

58% conviction (2yr+) 23% medium 19% new
30 out of 52 hedge funds have held CUE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -2%, value -33%

Value
-33%
Shares
-1%
Last quarter: funds added -2% more shares while total portfolio value only changed -33%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

8 → 8 → 9 → 7 → 13 new funds/Q
New funds entering each quarter: 8 → 9 → 7 → 13. A growing number of institutions are discovering CUE each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 62% veterans vs 27% newcomers

62% veterans 12% 1-2yr 27% new
Entry-cohort mix of 52 holders: 32 (62%) are 2+ year veterans, 6 entered 1–2 years ago, and 14 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 8% AUM from top-100

8% from top-100 AUM funds
15 of 51 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
1.9
out of 10
Low Exit Risk
Exit risk score 1.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CUE

In 2026 Q1, 18 hedge funds were net buyers of CUE (13 opened a new position, 5 added to an existing one), while 19 reduced or exited (10 trimmed, 9 sold completely) — a 49% buyer ratio, indicating roughly balanced activity. Net fund flow last quarter: +4 funds (more new holders than closures). Total institutional holders: 52.

Hedge Fund Ownership: CUE

How many hedge funds hold CUE — quarterly history vs. share price
Quarterly hedge fund ownership of CUE vs. share price

Market Analysis: CUE

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CUE

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cue Biopharma Inc (CUE) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CUE has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
CUE
nan%
XLV
+2.1%

CUE outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
CUE
nan%
XLV
+3.2%

Since the filing became public, CUE outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 1 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
1.3
/ 10
conviction
Hedge Fund Positioning: CUE
52 + Investors

Track Smart Money conviction in CUE. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 52 48 8.33%
13F Shares 21M 22M -1.52%
Total Value $5M $7M -33.38%
New Positions 13 7 +6
Increased Positions 5 8 -3
Closed Positions 9 11 -2
Reduced Positions 10 13 -3
Total Calls 0 0 -
Total Puts 1 0 100%
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: CUE

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

52 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CUE. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CUE holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lion Point Capital, LP 3.03% 2,202,854 $506K
2 Bleichroeder LP 0.27% 6,819,164 $1.6M
3 GC Wealth Management RIA, LLC 0.04% 4,631,644 $1.1M
4 Advisory Research Inc 0.01% 257,225 $59K
5 Texas Capital Bank Wealth Management Services Inc 0.01% 397,421 $91K
6 Diadema Partners LP 0.01% 131,997 $30K
7 Advisortrust Partners, LLC 0.00% 50,000 $11K
8 Angeles Wealth Management, LLC 0.00% 310,000 $71K
9 Robertson Stephens Wealth Management, LLC 0.00% 478,500 $110K
10 Persistent Asset Partners Ltd 0.00% 33,369 $8K
11 Chicago Partners Investment Group LLC 0.00% 85,937 $50K
12 Prevail Innovative Wealth Advisors, LLC 0.00% 18,987 $4K
13 Dauntless Investment Group, LLC 0.00% 2,416
14 Visionary Wealth Advisors 0.00% 29,285 $7K
15 Sigma Planning Corp 0.00% 38,750 $9K
16 SeaCrest Wealth Management, LLC 0.00% 10,000 $2K
17 Gleason Group, Inc. 0.00% 6,000 $1K
18 NFSG Corp 0.00% 3,000
19 Renaissance Technologies LLC 0.00% 213,828 $49K
20 XTX Topco Ltd 0.00% 15,124 $3K
21 Stifel Financial Corp 0.00% 246,556 $57K
22 Golden State Wealth Management, LLC 0.00% 2,000
23 Physician Wealth Advisors, Inc. 0.00% 1,006
24 Vanguard Fiduciary Trust Co 0.00% 543,585 $125K
25 Vanguard Capital Management LLC 0.00% 2,457,452 $565K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cue Biopharma Inc (CUE)

What does the Smart Money Trend signal show for CUE?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added CUE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CUE?

More sellers than buyers — 49% buying: Last quarter: 19 funds reduced or exited vs 18 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for CUE holders?

Smaller funds dominant — 8% AUM from top-100: 15 of 51 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CUE?

58% of holders stayed for 2+ years: 30 out of 52 hedge funds have held CUE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Cue Biopharma Inc (CUE) following the 2026 Q1 hedge fund 13F filings?

As of today, CUE has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), CUE has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →